NCT03278080

Brief Summary

The purpose of this study is to set an optimal measurement time for assessing driving ability in a driving simulator in healthy volunteers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 8, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 11, 2017

Completed
11 days until next milestone

Study Start

First participant enrolled

September 22, 2017

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 25, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 25, 2017

Completed
Last Updated

February 28, 2025

Status Verified

October 1, 2017

Enrollment Period

1 month

First QC Date

September 8, 2017

Last Update Submit

February 26, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Standard Deviation of Lateral Position (SDLP)

    60 min.

Secondary Outcomes (2)

  • Distance Coefficient of Variation (DCV)

    25 min.

  • Brake Reaction Time (BRT)

    15 min.

Study Arms (1)

driving test

OTHER
Other: Road-tracking testOther: Car-following testOther: Harsh-braking test

Interventions

Driving with simulator program for SDLP measurement

driving test

Driving with simulator program for DCV measurement

driving test

Driving with simulator program for BRT measurement

driving test

Eligibility Criteria

Age21 Years - 64 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Body mass index (BMI) ≥18.5 and \<25.0 kg/m2 at screening inspection
  • No visual impairment (enable to correct the vision with eyeglasses or contact lens)
  • Receive a prior explanation on the study, able to accept its content, and capable to provide voluntary written consent for participation in this study

You may not qualify if:

  • History of drug and food allergy
  • Routinely drink alcohol before bedtime
  • Inappropriate for enrollment in this study was judged by principal investigator or subinvestigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taisho Pharmaceutical Co., Ltd selected site

Fukuoka, Japan

Location

Study Officials

  • Shigeru Okuyama

    Taisho Pharmaceutical Co., Ltd.

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 8, 2017

First Posted

September 11, 2017

Study Start

September 22, 2017

Primary Completion

October 25, 2017

Study Completion

October 25, 2017

Last Updated

February 28, 2025

Record last verified: 2017-10

Locations